Panacea Biotec touches the roof on bagging additional order from UNICEF
Panacea Biotec is locked its upper circuit limit at Rs. 538.90, up by 25.65 points or 5.00% from its previous closing of Rs. 513.25 on the BSE.
The scrip opened at Rs. 524.05 and has touched a high and low of Rs. 538.90 and Rs. 520.15 respectively. So far 35427 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 549.05 on 21-Apr-2025 and a 52 week low of Rs. 112.70 on 04-Jun-2024.
Last one week high and low of the scrip stood at Rs. 549.05 and Rs. 496.85 respectively. The current market cap of the company is Rs. 3294.07 crore.
The promoters holding in the company stood at 72.48%, while Institutions and Non-Institutions held 2.65% and 24.87% respectively.
Panacea Biotec has bagged additional order from United Nations International Children's Emergency Fund (UNICEF) for supply of 40 million doses of its bivalent oral polio vaccine (bOPV) worth around $5.20 million (around Rs 44 crore) in Q3CY2025.
Panacea Biotec is a leading research-based Biotechnology Company with established research, manufacturing and marketing capabilities.
